(Q46190356)

20 December 2017

title

Integrating genomics and proteomics-oriented biomarkers to comprehend lung cancer (English)

1 reference

20 December 2017

1 reference

1 reference

Nagathihalli S Nagaraj

series ordinal

1

1 reference

20 December 2017

Om V Singh

series ordinal

2

1 reference

20 December 2017

language of work or name

English

0 references

publication date

1 March 2009

1 reference

20 December 2017

Expert Opinion on Medical Diagnostics

published in

1 reference

20 December 2017

volume

3

1 reference

20 December 2017

issue

2

1 reference

20 December 2017

page(s)

167-180

1 reference

20 December 2017

Multidisciplinary management of lung cancer

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

An overview of lung cancer genomics and proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Strategies for discovering novel cancer biomarkers through utilization of emerging technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Discordant protein and mRNA expression in lung adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

A five-gene signature and clinical outcome in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

High-resolution analysis of DNA copy number using oligonucleotide microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

A comparison of DNA copy number profiling platforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Methods and biomarkers for the diagnosis and prognosis of cancer and other diseases: towards personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Isolation of a novel human lung-specific gene, LUNX, a potential molecular marker for detection of micrometastasis in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Chemosensitivity prediction by transcriptional profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Non-overlapping and non-cell-type-specific gene expression signatures predict lung cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Somatic mutations affect key pathways in lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Comparison of gene expression and DNA copy number changes in a murine model of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Pulmonary resection in octogenarians with stage I nonsmall cell lung cancer: a 22-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

A high-throughput method to monitor the expression of microRNA precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Differential analysis of two-dimension gel electrophoresis profiles from the normal-metaplasia-dysplasia-carcinoma tissue of human bronchial epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Identification and validation of S100A7 associated with lung squamous cell carcinoma metastasis to brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Proteomic patterns of tumour subsets in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Proteomic signatures for histological types of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Deep proteome profiling of sera from never-smoked lung cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

The next wave in metabolome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Towards discovery-driven translational research in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Moving cancer diagnostics from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Integrative analysis of the cancer transcriptome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Genome-wide in silico identification of transcriptional regulators controlling the cell cycle in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

The cancer translational research informatics platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Mining the plasma proteome for cancer biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Molecular damage in the bronchial epithelium of current and former smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Application of mitochondrial genome information in cancer epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Proteomic analysis of cytokeratin isoforms uncovers association with survival in lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Characterization of gene expression in clinical lung cancer materials by two-dimensional polyacrylamide gel electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Usefulness of TA02 (napsin A) to distinguish primary lung adenocarcinoma from metastatic lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Processing of pulmonary surfactant protein B by napsin and cathepsin H

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Protein profiles associated with survival in lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Biomarkers for the lung cancer diagnosis and their advances in proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Proteomics as a method for early detection of cancer: a review of proteomics, exhaled breath condensate, and lung cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Tumor metastasis: mechanistic insights and clinical challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Isolation of rare circulating tumour cells in cancer patients by microchip technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Detection of mutations in EGFR in circulating lung-cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

RAS is regulated by the let-7 microRNA family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

The tumor suppressor microRNA let-7 represses the HMGA2 oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

The let-7 microRNA reduces tumor growth in mouse models of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

p53-mediated activation of miRNA34 candidate tumor-suppressor genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Methods and applications of antibody microarrays in cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Role of oncoproteomics in the personalized management of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Circulating nucleosomes predict the response to chemotherapy in patients with advanced non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Applications of eTag trade mark assay platform to systems biology approaches in molecular oncology and toxicology studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Laser capture microdissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Detection of tumor markers with ProteinChip technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Prognostic value of combination of Cyfra 21-1, CEA and NSE in patients with advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Prognostic impact of Cyfra21-1 and other serum markers in completely resected non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Clinical utility of cytokeratins as tumor markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

ProGRP: a new biomarker for small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Three-Gene Prognostic Classifier for Early-Stage Non–Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

Tumor Markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in Patients with Non-Small Cell Lung Cancer as an Aid in Histological Diagnosis and Prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050902725125

10.1517/17530050902725125

21 January 2018

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017